DOCS Quote, Financials, Valuation and Earnings

GoodRx Holdings has a net margin of 45.17% compared to Doximity's net margin of 5.45%. Doximity's return on equity of 22.82% beat GoodRx Holdings's return on equity of 4.21%.

Doximity has a consensus price target of $60.94, signalling upside risk potential of 8.99%. On the other hand GoodRx Holdings has an analysts' consensus of $6.32 which suggests that it could grow by 44.55%. Given that GoodRx Holdings has higher upside potential than Doximity, analysts believe GoodRx Holdings is more attractive than Doximity.

Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. GoodRx Holdings pays out -- of its earnings as a dividend.

Doximity quarterly revenues are $138.3M, which are smaller than GoodRx Holdings quarterly revenues of $203M. Doximity's net income of $62.5M is higher than GoodRx Holdings's net income of $11.1M. Notably, Doximity's price-to-earnings ratio is 50.38x while GoodRx Holdings's PE ratio is 54.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 19.73x versus 2.11x for GoodRx Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings has a net margin of 45.17% compared to Doximity's net margin of 14.32%. Doximity's return on equity of 22.82% beat Spok Holdings's return on equity of 10.19%.

Doximity has a consensus price target of $60.94, signalling upside risk potential of 8.99%. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 21.29%. Given that Spok Holdings has higher upside potential than Doximity, analysts believe Spok Holdings is more attractive than Doximity.

Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.563, suggesting its less volatile than the S&P 500 by 43.737%.

Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.58% to investors and pays a quarterly dividend of $0.31 per share. Doximity pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

Doximity quarterly revenues are $138.3M, which are larger than Spok Holdings quarterly revenues of $36.3M. Doximity's net income of $62.5M is higher than Spok Holdings's net income of $5.2M. Notably, Doximity's price-to-earnings ratio is 50.38x while Spok Holdings's PE ratio is 21.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 19.73x versus 2.44x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Tempus AI has a net margin of 45.17% compared to Doximity's net margin of -26.6%. Doximity's return on equity of 22.82% beat Tempus AI's return on equity of --.

Doximity has a consensus price target of $60.94, signalling upside risk potential of 8.99%. On the other hand Tempus AI has an analysts' consensus of $65.50 which suggests that it could fall by -8.04%. Given that Doximity has higher upside potential than Tempus AI, analysts believe Doximity is more attractive than Tempus AI.

Doximity has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tempus AI has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Doximity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tempus AI offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity pays -- of its earnings as a dividend. Tempus AI pays out -0.8% of its earnings as a dividend.

Doximity quarterly revenues are $138.3M, which are smaller than Tempus AI quarterly revenues of $255.7M. Doximity's net income of $62.5M is higher than Tempus AI's net income of -$68M. Notably, Doximity's price-to-earnings ratio is 50.38x while Tempus AI's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity is 19.73x versus 12.98x for Tempus AI. Usually stocks with elevated PS ratios are considered overvalued.